On May 17, 2016, Bristol-Myers Squibb completed an expansion at its Devens, MA biologics facility designed to accelerate development of the companyﾒs growing portfolio of biologics medicines. The $280 million project added two new buildings to the 89-acre Devens campus: a Biologics Development Building for designing processes for the early production of investigational medicines, and a Clinical Manufacturing Building where investigational medicines will be produced to support clinical trials.